Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study
- PMID: 11195622
- PMCID: PMC6655240
- DOI: 10.1002/clc.4960240103
Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study
Abstract
Background: Association between raised low-density lipoprotein cholesterol (LDL-C) levels and high risk for coronary heart disease (CHD) is well established and taken into account in guidelines on coronary prevention.
Hypothesis: The relationship between risk for coronary heart disease (CHD) and the levels of fasting plasma triglycerides was studied in the cohort of the Turkish Adult Risk Factor Study, a representative random sample of an adult population.
Methods: In 829 men and 907 women aged > or =27 years (mean 48.5+/-11), plasma lipids and lipoproteins were measured by the enzymatic dry method in the postabsorptive state. A sample of values was validated in a reference laboratory. Apoliprotein (apo) A-I and B were measured by the turbidimetric immunoassay using commercial kits in part of the cohort. Blood pressure and anthropometric measurements were made. Criteria for the diagnosis of CHD were based on history, cardiovascular examination, and Minnesota coding of resting electrocardiograms. Coronary heart disease was diagnosed in about 7% of the subjects. Participants were divided into four categories depending on their triglyceride levels: I = < 100 mg/dl (282 men, 400 women), II = 100-139 mg/dl (204 men, 228 women), III = 140-212 mg/dl (188 men, 180 women), and IV = > or = 212 mg/dl (155 men, 99 women).
Results: After adjustment for age, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, smoking, and body mass index by logistic regression analysis, and after assigning the CHD risk of 1 to Category I, the relative risk for men and women combined rose to 1.42 in Category III (p<0.045) while it diminished to 0.94 in Category IV (p = 0.79). In women, the odds ratio (OR) rose gradually up to 1.78 (p< 0.025) in Category III, only to decline in Category IV. The OR in men was slightly, insignificantly, and equally elevated in Categories III and IV. Patients with CHD in Category III were not distinguished from those in Category IV by the studied risk parameters. It was suggested that high risk for CHD--particularly in subjects with slightly elevated or normal cholesterol levels-is often not reflected by extreme increases of fasting triglycerides but best by modest elevations (140-212 mg/dl), which serve better as a marker of triglyceride-rich lipoprotein particles. This knowledge may prove to be of value in population screening and individual risk assessment.
Similar articles
-
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.Atherosclerosis. 2003 May;168(1):81-9. doi: 10.1016/s0021-9150(03)00025-x. Atherosclerosis. 2003. PMID: 12732390
-
[Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].Anadolu Kardiyol Derg. 2005 Dec;5(4):271-7. Anadolu Kardiyol Derg. 2005. PMID: 16330391 Turkish.
-
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7. Am Heart J. 2003. PMID: 14660998
-
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y. Curr Diab Rep. 2019. PMID: 31754844 Review.
-
Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol.Anadolu Kardiyol Derg. 2002 Dec;2(4):315-22. Anadolu Kardiyol Derg. 2002. PMID: 12460830 Review.
Cited by
-
Hypertriglyceridemia and risk of coronary heart disease.Curr Cardiol Rep. 2002 Nov;4(6):488-93. doi: 10.1007/s11886-002-0112-7. Curr Cardiol Rep. 2002. PMID: 12379171 Review.
References
-
- Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: An eight‐year follow‐up in the Copenhagen Male Study. Circulation 1998; 97: 1029–1036 - PubMed
-
- Egger M, Davey Smith G, Pflüger D, Altpeter E, Elwood PC: Triglycerides as a risk factor for ischaemic heart disease in British men: Effect of adjusting for measurement error. Atherosclerosis 1999; 143: 275–284 - PubMed
-
- Genest JJ, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DN, Schaefer EJ: Lipoprotein cholesterol, apolipoprotein A‐I and B and lipoprotein(a) abnormality in men with premature coronary heart disease. J Am Coll Cardiol 1992; 19: 792–802 - PubMed
-
- Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J‐P: Small, dense low‐density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 1997; 95: 69–75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources